These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cardiovascular response to injections of enkephalin in the pressor area of the ventrolateral medulla. Punnen S; Willette R; Krieger AJ; Sapru HN Neuropharmacology; 1984 Aug; 23(8):939-46. PubMed ID: 6090967 [TBL] [Abstract][Full Text] [Related]
9. Enkephalins induce a centrally mediated rise in blood pressure in rats. Petty MA; de Jong W Brain Res; 1983 Feb; 260(2):322-5. PubMed ID: 6299461 [TBL] [Abstract][Full Text] [Related]
10. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat. Laurent S; Schmitt H Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158 [TBL] [Abstract][Full Text] [Related]
11. The effect of intracerebroventricular D-ALA2 methionine enkephalinamide and naloxone on cardiovascular parameters in the cat. Lathers CM; Tumer N; Kraras CM Life Sci; 1988; 43(26):2287-98. PubMed ID: 3210904 [TBL] [Abstract][Full Text] [Related]
12. Effects of opiate receptor drugs injected intracerebrally into the normovolemic and hypovolemic monkey. Kregel KC; Reynolds DG; Gurll NJ; Gisolfi CV Peptides; 1985; 6(6):1161-6. PubMed ID: 3010258 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of opiate receptors in the dorsal pontine tegmentum inhibits reflex contraction of the urinary bladder. Willette RN; Morrison S; Sapru HN; Reis DJ J Pharmacol Exp Ther; 1988 Jan; 244(1):403-9. PubMed ID: 2891844 [TBL] [Abstract][Full Text] [Related]
14. The opioid peptide analog D-Ala2-Met-enkephalinamide decreases bile flow by a central mechanism. Bergasa NV; Zhou J; Ravi J; Shi Q Peptides; 1999; 20(8):979-86. PubMed ID: 10503777 [TBL] [Abstract][Full Text] [Related]
15. Central cardiovascular actions of D-Ala2-Met5-enkephalinamide in the rat: effects of naloxone and nucleus reticularis gigantocellularis lesion. Wong TM; Chan SH; Tse SY Neurosci Lett; 1984 May; 46(3):249-54. PubMed ID: 6377125 [TBL] [Abstract][Full Text] [Related]
16. Effects of [D-Ala2]-methionine-enkephalin on blood pressure, heart rate, and baroreceptor reflex sensitivity in conscious cats. Yukimura T; Stock G; Stumpf H; Unger T; Ganten D Hypertension; 1981; 3(5):528-33. PubMed ID: 7298107 [TBL] [Abstract][Full Text] [Related]
17. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine. Randich A; Robertson JD; Willingham T Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421 [TBL] [Abstract][Full Text] [Related]
18. Enhanced hemodynamic response to [D-ALA2,D-MET5]-methionine enkephalin (DAME) in streptozotocin-induced diabetic rats is reversed by insulin replacement. Severson K; Tackett RL Life Sci; 1998; 62(24):2219-29. PubMed ID: 9627081 [TBL] [Abstract][Full Text] [Related]
19. Vagally mediated reflex and cardiac slowing induced by loperamide in rats. Gautret B; Schmitt H Eur J Pharmacol; 1985 Jan; 107(2):157-60. PubMed ID: 2984000 [TBL] [Abstract][Full Text] [Related]
20. Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart. Musha T; Satoh E; Koyanagawa H; Kimura T; Satoh S J Pharmacol Exp Ther; 1989 Sep; 250(3):1087-91. PubMed ID: 2550614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]